AE098, AE456, AE510, AE596, AE597 and AE598 antibodies recognize the HIV-1 envelope protein by immunofluorescence
DOI:
https://doi.org/10.24450/journals/abrep.2019.e6Abstract
The recombinant antibodies AE098, AE456, AE510, AE596, AE597 and AE598 detect by immunofluorescence the HIV-1 envelope protein in paraformaldehyde-fixed cells. AE603 and AE724 antibodies do not.
Introduction
The HIV-1 envelope protein is first inserted in the endoplasmic reticulum, then transported through the Golgi apparatus to the cell surface and endosomes. In the Golgi apparatus, it is proteolytically cleaved into the surface protein gp120 and the transmembrane protein gp41. Here we describe the ability of six recombinant antibodies to successfully detect the HIV-1 envelope protein by immunofluorescence in gp160-transfected Hela cells.
Materials & Methods
Antibodies: ABCD_AE098, ABCD_AE456, ABCD_AE510, ABCD_AE596, ABCD_AE597, ABCD_AE598, ABCD_AE603 and ABCD_AE724 antibodies (ABCD nomenclature, http://web.expasy.org/abcd/) target the gp41 subunit of the HIV-1 envelope protein (Table 1). They were produced by the Geneva Antibody Facility (http://unige.ch/medecine/antibodies/; Blanc et al., 2014) as mini-antibodies with the antigen-binding scFv fused to a mouse Fc. The synthesized scFv sequences (GeneArt, Invitrogen) correspond to the sequence of the variable regions joined by a peptide linker (GGGS)3 (see Table 1 for clone names and references). HEK293T cells (growing in DMEM GlutaMAXTM (Gibco, #31966) supplemented with 8% Fetal Bovine Serum (Gibco, #10270)) were transiently transfected with the vector coding for the scFv-Fc of each antibody. Supernatants (~5 mg/L) were collected after 5 days.
Ab | Clone | Epitope | Ref erence |
AE098 | 3D6 | SGKLICTTAVPWNAS | Felgenhauer 1990 |
AE456 | K14 | --------------- | van der Donk 1994 |
AE510 | No.86 | YLKDQQLLGIWGCSGLICTTAVPWNASWSNKSL | Moran 1993 |
AE596 | DaB2B3 | --------------- | David 1995 |
AE597 | NG3B7 | --------------- | David 1995 |
AE598 | DZ33 | --------------- | David 1995 |
AE603 | M25 | --------------- | Watkins 1996 |
AE724 | 2F5 | ELDKWA | Kunert 1998 |
Antigen: HeLa cells (growing in DMEM GlutaMAXTM supplemented with 10% Fetal Bovine Serum) cultured on a glass coverslip (Menzel-Gläser, 22x22 mm) were transfected 3 days before the experiment with the VB9 vector coding for the full-length HIV-1 envelope glycoprotein gp160 (UniProt #P03375).
Protocol: The whole procedure was carried out at room temperature. Transfected HeLa cells were rinsed once with PBS, fixed with PBS + 4% paraformaldehyde (w/v) (Applichem, #A3013) for 30 min, and blocked with PBS + 40 mM ammonium chloride (NH4Cl) (Applichem, #A3661) for 5 min. Cells were then permeabilized in PBS + 0.2% saponin (w/v) (Sigma, #S7900) for 10 min, washed once (5 min) with PBS + 0.2% (w/v) BSA (PBS-BSA), and incubated for 30 min with the antibody-containing supernatants (non-diluted). After 3 washes (5 min) with PBS-BSA, cells were incubated for 30 min in PBS-BSA with secondary goat anti-mouse IgG conjugated to AlexaFluor-488 (1:300, Molecular Probes, #A11029). After 3 washes (5 min) with PBS-BSA, cells were mounted on slides (Menzel-Gläser, 76x26 mm) with Möwiol (Hoechst) + 2.5% (w/v) DABCO (Fluka, #33480). Pictures were taken using a Zeiss LSM700 confocal microscope, with a 63x Neofluar oil immersion objective.
Results
Antibodies AE098, AE456, AE510, AE596, AE597 and AE598 detected specifically a signal in transfected cells reminiscent of an ER network (Fig. 1). The precise labelling pattern of each specific antibody was not specifically studied here. No signal was detected in non-transfected cells (data not shown) or when the primary antibody was omitted (Fig. 1). Antibodies AE603 and AE724 yielded no signal above background levels (Fig. 1)
Conflict of interest
The authors declare no conflict of interest.
References
Blanc C, Zufferey M, Cosson P. Use of in vivo biotinylated GST fusion proteins to select recombinant antibodies. ALTEX. 2014;31(1):37-42. PMID:24100547
David D, Goossens D, Desgranges C, Thèze J, Zouali M. Molecular characterization of human monoclonal antibodies specific for several HIV proteins: analysis of the VH3 family expression. Immunol Lett. 1995 47(1-2):107-12. PMID:8537086
Felgenhauer M, Kohl J, Rüker F. Nucleotide sequences of the cDNAs encoding the V-regions of H- and L-chains of a human monoclonal antibody specific to HIV-1-gp41. Nucleic Acids Res. 1990 18(16):4927. PMID:1697678
Kunert R, Rüker F, Katinger H. Molecular characterization of five neutralizing anti-HIV type 1 antibodies: identification of nonconventional D segments in the human monoclonal antibodies 2G12 and 2F5. AIDS Res Hum Retroviruses. 1998 14(13):1115-28. PMID:9737583
Moran MJ, Andris JS, Matsumato Y, Capra JD, Hersh EM. Variable region genes of anti-HIV human monoclonal antibodies: non-restricted use of the V gene repertoire and extensive somatic mutation. Mol Immunol. 1993 30(16):1543-51. PMID:8232339
van der Donk EM, Schutten M, Osterhaus AD, van der Heijden RW. Molecular characterization of variable heavy and light chain regions of five HIV type 1-specific human monoclonal antibodies. AIDS Res Hum Retroviruses. 1994 10(12):1639-49. PMID:7888223
Watkins BA, Davis AE, Fiorentini S, di Marzo Veronese F, Reitz MS Jr. Evidence for distinct contributions of heavy and light chains to restriction of antibody recognition of the HIV-1 principal neutralization determinant. J Immunol. 1996 156(4):1676-83. PMID:8568275
Downloads
Published
Section
How to Cite
License
Alguns direitos reservados 2019 The author(s)
This work is licensed under a Creative Commons Attribution 4.0 International License.